Study of JNP-0101 for the delivery of nine amino acid peptide leuprolide.

Trial Profile

Study of JNP-0101 for the delivery of nine amino acid peptide leuprolide.

Completed
Phase of Trial: Phase I

Latest Information Update: 26 Aug 2016

At a glance

  • Drugs Leuprorelin (Primary)
  • Indications Unspecified
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics; Proof of concept
  • Most Recent Events

    • 26 Aug 2016 New trial record
    • 04 Aug 2016 According to a Juniper Pharmaceuticals media release, data from this study is published in Journal of Controlled Release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top